Clinical Outcomes of Ticagrelor versus Clopidogrel in Patients with Chronic Kidney Disease and Acute Myocardial Infarction: A Real-World Cohort Study
In CKD patients with AMI, ticagrelor was associated with reduced all-cause mortality compared to clopidogrel, without an increased risk of major bleeding. These findings highlight the need for further prospective studies to confirm ticagrelor's benefits and inform optimal antiplatelet strategies in this high-risk population.
Authors
- Ching-Chung Hsiao (ORCID: https://orcid.org/0000-0003-3782-8189)
- Wei-Chiao Sun (ORCID: https://orcid.org/0000-0002-9154-9917)
- Lin Cc
- Chieh-Li Yen
- Shu-Chun Huang
- Hsin-Fu Lee
- Wen-Yu Ho
- Jia-Jin Chen
Institutions
- Chang Gung University of Science and Technology (TW)
- Chang Gung University (TW)
- Chang Gung Memorial Hospital (TW)
- Taipei Municipal YangMing Hospital (TW)
- Linkou Chang Gung Memorial Hospital (TW)
- Taipei City Hospital (TW)
Publication Details
- Journal
- Cardiorenal Medicine
- Published
- 2026-01-22
- DOI
- https://doi.org/10.1159/000550521
- Primary Topic
- Antiplatelet Therapy and Cardiovascular Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Chang Gung Medical Foundation
- Center for Big Data Analytics and Statistics, Chang Gung Memorial Hospital
- Center for Big Data Analytics, University of Texas at Austin